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Abstract: Irritable bowel syndrome (IBS) patients frequently experience affective disorders and psychiatric outpatients 
frequently meet criteria for IBS. The exact nature of this co-morbidity is not clear. 34 patients with Rome-II diagnosed 
IBS were recruited from a Gastroenterology clinic. Patients with social anxiety disorder (10 SSRI-remitted and 7 un-
treated subjects) were used as a psychiatric comparison, 28 normal subjects from our register were included as a fourth 
group (Volunteers). Depressive and anxiety symptoms were measured by the Beck Depression Inventory (BDI) and 
Spielberger Trait Anxiety Inventory (STAI), respectively. Personality traits were measured with the Swedish universities 
Scales of Personality (SSP). IBS subjects had BDI and STAI scores intermediate between those of volunteers and patients, 
despite their lack of a co-morbid psychiatric diagnosis. A principle component factor analysis of the SSP dataset corre-
sponded closely to the solution published with other samples. ANOVA revealed significant between-group differences for 
7 of the 13 SSP variables. 
Keywords: IBS, anxiety, depression, subsyndromal, personality. 
INTRODUCTION 
 Irritable bowel syndrome (IBS) is a common condition, 
with estimated prevalence rates of 10-15% [1]. There is con-
siderable evidence for co-morbidity between IBS and affec-
tive disorders [2,3] although the relationship is complex [4]. 
For example in gastroenterology clinics, recently referred 
IBS patients have more anxiety than depressive symptoms 
[5], whereas more chronic attendees have less anxiety than 
depression [6]. The reasons for this are likely confounded by 
factors such as age, chronicity, help-seeking behaviours and 
family history [7-9]. 
 Functional somatic syndromes, including IBS, have been 
shown to be associated with depression or anxiety at a higher 
rate than either healthy controls or subjects with phenome-
nologically-similar medical complaints of known organic 
pathology [3]. 
 Personality factors in IBS have been relatively understud-
ied, and the first study to recruit subjects from a representa-
tive community sample with physician diagnosis was only 
recently published [10]. This study compared IBS patients, 
IBS non-consulting subjects and normal controls recruited 
from the Swedish population registry using the Karolinska 
Scales of Personality (KSP) and Symptom Checklist 90  
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(SCL-90). IBS subjects who had not consulted a physician 
had similar scores to IBS patients on most measures; both 
IBS groups differed from controls on personality, interper-
sonal, and psychological distress measures. 
 A clearer understanding of the personality and negative 
affectivity characteristics of IBS patients is essential to en-
sure targeted and effective treatments for this condition. This 
is especially important given that both pharmacotherapy 
(SSRIs) and psychological treatments (Cognitive Behav-
ioural Therapy - CBT) that are mainstream treatments for 
mood disorders are being increasingly used in IBS with 
some efficacy [11,12]. 
 The aim of the present study was to assess personality 
using an enhanced version of the KSP in a well defined 
group of IBS patients attending an outpatient gastroenterol-
ogy service. We wanted to compare personality and negative 
affectivity ratings with a well defined physician diagnosed 
group of patients with an anxiety disorder and an age 
matched volunteer group. A cohort of patients with untreated 
and treated social anxiety disorder (SAnD) was available to 
us at the time this study was conducted. This provided a 
convenient anxiety disorder comparator that reflected the full 
range of clinical anxiety severity. Our clinical and research 
experience [13,14] is that patients with untreated SAnD ex-
hibit very high levels of anxiety as measured by the assess-
ment scales used here. 
 Our hypotheses were that IBS patients would be more 
anxious and have higher depression scores than volunteers 
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but lower than untreated SAnD patients. If correct this would 
support the common clinical observation that IBS patients, 
whilst not suffering from clinically significant psychopa-
thology, may experience subsyndromal mood/anxiety symp-
toms and personality traits that may be relevant to treatment 
options and clinical outcome. 
MATERIALS AND METHODOLOGY 
Subjects 
 All of the subjects in this study (see Table 1 for numbers) 
had agreed to participate in a series of studies investigating 
the role of the monoamine systems in either SAnD or IBS. 
The local regional ethics committee approved these studies; 
supplemental results will be presented in future papers. The 
IBS patients were recruited by JQS from a gastroenterology 
outpatient clinic held at the Bristol Royal Infirmary (ie: IBS-
consulters). Patients with SAnD came from the Psychophar-
macology Unit outpatient department at the same hospital 
and were under the clinical care of SDH and JP. The normal 
volunteers were recruited from a volunteer register held at 
the Psychopharmacology Unit. All subjects, including volun-
teers, were assessed for medical and psychiatric co-
morbidity prior to entry into this study by clinical interview 
(JH) and supplementary rating scales as indicated; co-morbid 
subjects were excluded. No subject had a current or recent (6 
months) co-morbid DSM-IV diagnosis, or other significant 
medical condition. Remitted SanD subjects were taking a 
serotonergic medication (paroxetine); no other subjects were 
taking a serotonergic or psychotropic medication. Subjects 
were not paid for their participation, and decision to enter 
into the study did not influence clinical care. 
 Bowel habit was assessed according to Rome II Criteria, 
and IBS subtype classified as constipation-predominant (C-
IBS), diarrhoea-predominant (D-IBS), or alternating (A-IBS) 
according to established convention [15]. 
Measures 
 Basic demographic data were collected by clinical inter-
view. 
 Depressive symptoms in the studies were measured by 
the Beck Depression Inventory (BDI) [16]. Trait anxiety was 
recorded using the Spielberger State-Trait Anxiety Inven-
tory, Trait Scale (STAI) [17]. 
 Personality traits were measured with the Swedish uni-
versities Scales of Personality (SSP) [18]. The SSP is a 
shortened and psychometrically enhanced version of the 
Karolinska Scales of Personality (KSP) [19] that improves 
upon face validity, internal consistency and response differ-
entiation. The SSP contains 91 items divided into 13 scales 
with seven items each: Somatic Trait Anxiety, Psychic Trait 
Anxiety, Stress Susceptibility, Lack of Assertiveness, De-
tachment, Embitterment, Trait Irritability, Mistrust, Impul-
siveness, Adventure Seeking, Social Desirability, Verbal 
Trait Aggression, and Physical Trait Aggression. The items 
are rated on a 4-point Likert scale, where 1 = “Does not ap-
ply at all”, 2= “Does not apply very well”, 3= “Applies 
pretty much” and 4 =“Applies completely”. The SSP was 
standardized in a representative national sample of 741 
Swedes in which Cronbach’s alpha values varied between 
0.59 and 0.84. The three-factor solution in the original publi-
cation corresponds to well-known personality theories [20]: 
Factor 1 is related mainly to Neuroticism, Factor 2 is related 
to Aggressiveness and Factor 3 forms a broad Extraversion 
factor. This structure has recently been confirmed in a large 
community sample of women [21]. 
 Normative standard scores (T-scores) are calculated for 
each gender separately. In the original work the T-scale is 
constructed to have a mean of 50 and a SD of 10. Our clini-
cians have consistently found it to be more useful to con-
struct the T-scale with a mean of 0 using the same standard 
deviation of 10. In this method, the magnitude as well as 
direction of deviation from the mean is more apparent in 
graphical representations, and we can more easily convey 
these results to our patients. This latter method is used in this 
article. 
Statistical Analyses 
 The statistical analysis was conducted using SPSS v11.5 
for Windows (SPSS Inc, Chicago, IL, USA). An alpha level 
of 0.05 was used, with the Bonferroni adjustment applied to 
all pair wise tests. Confidence intervals are displayed where 
available. Waller-Duncan post-hoc analysis, with Type 
I/Type II Error Seriousness Ratio = 100, was also used to 
elucidate homogeneous subsets [22]. 
 Principal components factor analysis was performed on 
the complete SSP data set. The Kaiser criterion was applied 
to exclude eigenvalues less than 1 and the scree plot was 
reviewed. Orthogonal (Varimax) rotation was undertaken 
and the limit for factor loadings set to 0.45, as in other analy-
ses of SSP data [23]. 
 Levene's Test was used to verify equality of variances; 
non parametric tests are used when equality is not demon-
strated. Two-sided tests are employed throughout. Pearson 
correlation co-efficients were reported after examining scat-
ter plots. 
RESULTS 
Characteristics of the Sample 
 Demographic data from the 79 subjects in this study are 
presented in Table 1. There were significantly more men 
than women in the SAnD pre treatment group (X 
2
=7, df=1, 
p=0.008), and more women than men in the C-IBS (X 
2
=4.455, df=1, p=0.035) subgroup. No significant impact of 
sex on BDI (Kruskal-Wallis X 
2 
= 2.122, df=1, p=0.145) or 
STAI (Kruskal-Wallis X 
2 
= 0.412, df=1, p=0.521) was seen. 
There was no difference in age between any subject group, 
and the age of this sample was remarkably similar to the 
mean age of 40.9 years (SD = 12.7) cited in the SSP valida-
tion data [18]. Only two IBS patient met criteria for the A-
IBS group; this small group was thus excluded from subse-
quent statistical analyses. 
BDI 
 Significant between-group differences were shown for 
BDI means (F[3,42] = 12.025, p<0.001). Volunteers had the 
lowest scores, which were significantly less than those of 
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IBS subjects (p=0.019, 95% CI = -0.75 to -12.48), post 
treatment SAnD (p=0.01, 95% CI = -3.47 to -16.89) and pre 
treatment SAnD groups (p<0.001, 95% CI = -7.79 to -22.58). 
IBS patients also had significantly lower scores than pre 
treatment SAnD groups (p=0.005, 95% CI = -1.93 to -15.20). 
No other between-group (Bonferroni-adjusted) comparison 
reached statistical significance. There was no relationship 
between age (r
 
= -0.155, p=0.305) or sex (Z = -1.424, 
p=0.154) and BDI. Waller-Duncan analysis confirms the 
trend suggested in Fig. (1) of three distinct subgroups at al-
pha = 0.05; namely a volunteer group (mean = 1.70), a com-
bined IBS and SAnD post treatment group (means = 8.32, 
11.88 respectively), and a SAnD pre- treatment group (mean 
= 16.88). 
Table 1. Demographic Details 
 
Subject Group n Sex Mean Age (95% CI) 
Volunteers 28 18 f /10 m 35.17 (29.19-41.14) 
IBS 34 24 f / 14 m 38.76 (34.93-42.60) 
 - IBS Constipation (C-IBS) 11  9 f / 2 m * 36.64 (30.05-43.22) 
 - IBS Diarrhoea (D-IBS) 21 10 f / 11 m 38.86 (33.59-44.12) 
 - IBS Alternating (A-IBS) 2 2 f / 0 m 49.50 (-20.38 – 119.38)  
Post Rx SAnD 10 5 f / 5 m 38.00 (30.63-45.37) 
Pre Rx SAnD 7 0 f / 7 m ** 39.00 (26.39-51.61) 
    
Total 79 44 f / 35 m 37.98 (35.28-40.69) 
* X 2=4.455, df=1, p=0.035; ** X 2=7, df=1, p=0.008. 
Spielberger Trait 
 Significant between-group differences were also seen in 
STAI scores (F[3,42] = 11.600, p<0.001). Again, volunteers 
had the lowest STAI scores, which were lower than those of 
IBS patients (p=0.014, 95% CI = -2.24 to -28.03), post 
treatment SAnD subjects (p<0.001, 95% CI = -11.39 to -
40.91) and pre treatment (p<0.001, 95% CI = -13.63 to -
46.17) SAnD subject results (see Fig. 2). IBS subjects results 
were also less than those of pre treatment SAnD subjects 
(p=0.046, 95% CI= -0.17 to -29.36). There was no effect of 
age (r= -0.149, p=0.322) or sex (Z=-0.563, p=0.574) on 
STAI. Waller-Duncan analysis yielded three distinct sub-
groups; viz a volunteer group (mean = 27.55), an IBS group 
(mean = 42.68), and a combined SAnD post- and pre- treat-
ment group (means = 53.70, 57.45 respectively). 
SSP 
 The principal component factor analysis for the complete 
data set is displayed in Table 2. Factor 1 consisted of 8 items 
measuring anxiety and negative emotions that will be re-
ferred to as Neuroticism (N). Factor 2 consisted of verbal and 
physical trait aggression and will be referred to as Aggres-
siveness (A). Factor 3 consisted of impulsiveness and adven-
ture seeking and will be summarised as Sensation Seeking 
(SS). Cronbach’s alpha for these three factors was 0.90, 0.48, 
0.57 respectively. 
 Subgroup factor analyses were not performed due to 
sample size limitations [24]. 
 One-way ANOVA revealed significant between-group 
differences for 7 of the 13 SSP variables, viz: Somatic Trait 
Fig. (1). 95% Confidence Interval of Beck Depression Inventory Score by Subject Group. 
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Anxiety (F[3,73] = 12.166, p<0.001), Psychic Trait Anxiety 
(F[3,73] = 20.048, p<0.001), Stress Susceptibility (F[3,73] = 
18.821, p<0.001), Lack of Assertiveness (F[3,73] = 11.030, 
p<0.001), Embitterment (F[3,73] =5.712, p=0.001), Trait 
Irritability (F[3,73] = 3.625, p=0.017) and Mistrust (F[3,73] 
= 12.281, p<0.001). Significant Bonferroni-adjusted pair 
wise comparisons are shown in Table 3, restricted to results 
involving the IBS patient subgroup. Table 4 presents SSP 
variables that separate into homogenous subsets at alpha = 
0.05 by Waller-Duncan analysis according to subject group. 
IBS Subtype Analysis 
 There was no difference between C-IBS and D-IBS sub-
jects according to BDI (p=0.854, 95% CI = -4.291 – 3.591) 
or STAI (p=0.957, 95% CI = -11.162 – 10.595). C-IBS sub-
jects scored less on the Lack of Assertiveness scale than did 
D-IBS subjects (Kruskal-Wallis X 
2
= 4.536, df=1, p=0.033), 
however no other significant differences were demonstrated. 
The SSP results are presented in Fig. (3). 
DISCUSSION 
 The BDI and STAI findings reported here confirm our 
clinical impression that patients with IBS often have anxiety 
and depressive scores at an intermediate level between nor-
mal volunteers and patients with clinical anxiety syndromes 
such as SAnD. Our results also demonstrate a tendency for 
IBS patients to experience anxiety at levels less than those 
seen in patients with SAnD who are currently clinically 
SSRI-remitted. This may reflect residual vulnerability and / 
or subsyndromal impairment in SSRI-remitted patients with 
anxiety disorders such as SAnD. 
 The relevance of these subsyndromal anxiety and depres-
sive scores in IBS patients is not known. A recent study 
demonstrated a significant role of chronic life stress as a pre-
dictor of IBS symptom intensity over 16 months, but found 
that BDI or STAI score did not significantly impact upon 
longitudinal symptom intensity [25]. 
 The mainstays of treatment for anxiety disorders are 
SSRIs and CBT, both of which are increasingly being used 
in the management of IBS. The SSRI paroxetine has been 
shown to improve abdominal pain, constipation and diarrhea 
associated with IBS, independent of lifetime history of an 
anxiety disorder [26] although our results suggest that sub-
syndromal anxiety may be relevant. It is not clear whether 
SSRI treatment of IBS is reducing this subsyndromal anxiety 
or whether their mechanism of action is via a direct effect on 
the gut, and research clearly needs to focus on this. 
 In terms of CBT, Lackner et al. recently demonstrated 
that catastrophizing cognitions account for part of the rela-
tionship between depression and pain in IBS patients [27] – 
suggesting a complex interplay of physiological, behavioral, 
and psychological factors. The relationship of IBS to psy-
chological symptoms such as depression is complex, how-
ever, with a case report providing evidence that depressive 
symptoms may be associated with a reduction of IBS symp-
toms in certain individuals [28]. 
 The SSP questionnaire is an increasingly popular meas-
ure of personality structure [21,23,29-31]. Additionally, the 
authors’ have (anecdotally) found it to be a useful measure in 
routine clinical psychiatric practice [32]. In our experience, 
patients with anxiety difficulties score positively on the  
 
Fig. (2). 95% Confidence Interval of Spielberger Trait Score by Subject Group. 
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Table 2. Principal Component Factor Analysis for Complete 
Data Set 
 
Component 
1 2 3 
SSP Variable 
“Neuroticism” “Aggressiveness” 
“Sensation  
Seeking” 
Somatic Trait  
Anxiety 
.810   
Psychic Trait  
Anxiety 
.905   
Stress  
Susceptibility 
.879   
Lack of  
Assertiveness 
.861   
Impulsiveness   .800 
Adventure  
Seeking 
  .807 
Detachment .610   
Embitterment .760   
Social  
Desirability 
   
Verbal Trait 
 Aggression 
 .818  
Physical Trait  
Aggression 
 .698  
Trait Irritability .584   
Mistrust .746   
    
Cronbach’s  
alpha 
0.9046 0.4848 0.5704 
Table 3. Bonferroni-Adjusted SSP Pair Wise Comparisons 
(IBS Subjects Only) 
 
Variable Relationship Significance (95% CI) 
Somatic Trait  
Anxiety 
Volunteer < IBS 
IBS < SAnD pre treatment 
p=0.002 (2.62 – 16.95) 
p=0.026 (-24.07 - -0.9751) 
Psychic Trait  
Anxiety 
Volunteer < IBS 
IBS < SAnD post treatment 
IBS < SAnD pre treatment 
p=0.024 (0.64 - 13.75) 
p=0.020 (-19.44 - -1.09) 
p<0.001 (-30.45 - -9.30) 
Stress  
Susceptibility 
Volunteer < IBS 
IBS < SAnD post treatment 
IBS < SAnD pre treatment 
p<0.001 (3.66 – 16.38) 
p=0.039 (-18.10 - -0.29) 
p=0.008 (-22.85 - -2.33) 
Lack of  
Assertiveness 
IBS < SAnD pre treatment P<0.001 (-26.23 - -5.72) 
Mistrust 
IBS < SAnD post treatment 
IBS < SAnD pre treatment 
P=0.016 (-18.98 - -1.32) 
p<0.001 (-29.42 - -9.08) 
 
variables somatic trait anxiety, psychic trait anxiety and 
stress susceptibility. Moreover, a score above 10 (ie: +1 SD) 
usually reflects a clinically evident trait and a score above 20 
(ie: +2 SD) almost invariably corresponds with a clinically 
evident impairment. Interestingly, we also find that clinical 
recovery is mirrored by a normalisation of these SSP vari-
ables, making this a useful tool to track progress collabora-
tively with our patients. 
 Fig. (4) shows the personality characteristics of IBS pa-
tients as measured by SSP. It is clear from this graph that 
these scores are all within +/- 1 SD of the general population 
mean (ie: +/- 10), despite 3 of the 13 scales being  
 
Table 4. SSP Waller-Duncan Homogeneous Subsets 
 
Variable Homogeneous Subset (Harmonic Mean) 
Somatic Trait Anxiety 
Volunteer (-5.91) 
 
IBS (3.88) 
SAnD post treatment (8.97) 
SAnD pre treatment (16.41)  
Psychic Trait Anxiety Volunteer (-0.23) IBS (6.97) 
SAnD post treatment 
(17.23) 
SAnD pre treatment 
(26.84) 
Stress Susceptibility Volunteer (-0.80) IBS (9.22) 
SAnD post treatment 
(18.41) 
SAnD pre treatment (21.81) 
 
Lack of Assertiveness 
Volunteer (0.09) 
IBS (3.63) 
SAnD post treatment 
(12.00) 
SAnD pre treatment (19.61)  
Detachment 
Volunteer (-0.85) 
IBS (2.26) 
SAnD post treatment (7.41) 
IBS (2.26) 
SAnD post treatment (7.41) 
SAnD pre treatment (13.53) 
  
Embitterment 
Volunteer (0.26) 
IBS (2.92) 
IBS (2.92) 
SAnD post treatment (9.09) 
SAnD post treatment (9.09) 
SAnD pre treatment (11.98) 
 
Trait Irritability 
Volunteer (-3.86) 
IBS (0.45) 
SAnD post treatment (1.90) 
SAnD post treatment (1.90) 
SAnD pre treatment (8.51) 
  
Mistrust 
Volunteer (-1.50) 
IBS (-1.07) 
SAnD post treatment (9.08) SAnD pre treatment (18.18)  
The Waller-Duncan k-ratio t-test compares type I & type II errors based on Bayesian principles; the chosen ratio of 100 corresponds to alpha = 0.05. Harmonic means are used as the 
samples sizes are unequal. As the underlying statistical requirements of Bayesian analyses differ from routine parametric analyses this provides a check of the robustness of the 
statistical findings – useful with the small sample size available here. 
Patient groups appearing in different vertical columns above (viz: homogeneous subsets) are thus statistically distinct at a Bayesian equivalent of alpha = 0.05. Groups appearing in 
the same vertical common are not statistically dissimilar. 
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significantly greater than those of our normal volunteers. 
These three indices (Somatic Trait Anxiety, Psychic Trait 
Anxiety, and Stress Susceptibility) describe personality as-
pects closely related to clinical anxiety syndromes, and the 
SAnD subjects rate particularly high on these. These results 
concur with the Karolinska Scales of Personality ratings in 
the Weinryb et al. study that showed higher scores for IBS 
patients than controls on four of five anxiety proneness 
scales [10]. Thus, our IBS subjects demonstrated subsyn-
dromal anxiety and depressive symptoms in the context of 
normal SSP personality profiles. Normal volunteers were 
screened to ensure the absence of anxiety disorders, which is 
reflected in their personality profiles. 
 Treatment seeking for IBS has been associated with an 
increase in the tendency to make somatic attributions for 
both gastroenterological symptoms and symptoms character-
istic of depression and anxiety states [33]. A logistic regres-
sion analysis in a population of nurses showed that subjects 
reporting a higher degree of neuroticism were at higher risk 
of being diagnosed with IBS [34]. Additionally, a study of 
ethnic Chinese subjects found that in patients with IBS the 
mean depression score of patients who sought any medical 
consultation was higher than that of those who did not [35]. 
The degree of anxiety, but not depressive illness was an in-
dependent factor associated with health care-seeking behav-
iour. The results from the SSP instrument in our study 
showed that IBS subjects had significantly lower levels of 
both somatic and psychic anxiety variables than SAnD pa-
tients with both variables rated at less than 1 SD away from 
the general population mean. 
 A recent cluster analysis of IBS treatment non-responders 
yielded three distinct groups: a psychiatrically-distressed 
high service utiliser group (group I), a psychiatrically-
distressed low service utiliser group (group II), and a tolerant 
group of low service utilisers (group III) [36]. Group III had 
more subjects with C-IBS symptoms than the other groups, 
and low levels of anxiety, consultation and pain. The IBS 
subtype analyses performed here produced only one signifi-
cant finding, namely that C-IBS subjects demonstrated lower 
Lack of Assertiveness SSP scores than D-IBS patients. Thus, 
our sample of C-IBS patients was more able to assert them-
selves in social situations [18] than those with D-IBS symp-
toms. Just how comparable our C-IBS cohort is to the Group 
III subjects of the other study is unclear, especially as these 
patients were less likely to present for treatment. 
 There are a number of potential limitations of this study 
that warrant discussion. 
 This study included IBS patients who were seeking 
treatment, and who had agreed in principle to take part in a 
study. No patient with IBS and a co-morbid depressive or 
anxiety disorder was eligible for inclusion in this study, al-
though only approximately 5% of patients seen in our gas-
troenterology clinic were excluded on this criterion. These 
selection biases may limit generalisation to other persons 
with IBS. 
 More women than men were seen in our sample of C-IBS 
patients, although the total IBS sample was sex-balanced. 
There is considerable evidence of a predominance of women 
with C-IBS type symptoms in other reports [37,38], although 
this is not invariably found [39]. Our sample did contain 
more men than women with pre-treatment SAnD; however 
there was no significant impact of sex on BDI or STAI, and 
SSP data is sex-adjusted. Post-hoc analysis of the baseline 
demographic data is otherwise unremarkable. 
 The BDI and STAI scales were chosen due to their com-
mon use in this field and the availability of these data; never-
theless we are aware of the potential for symptom overlap 
with somatic symptoms of IBS. 
 
(Fig. 3) contd….. 
 
Fig. (3). 95% Confidence Interval of SSP Variables by Subject Group. 
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Fig. (4). Average SSP T-Scores. 
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 The factor analysis may be underpowered. There is little 
consensus in this area, as although some authors recommend 
that the subjects-to-variables ratio should be no lower than 5 
(ie: n= 75) [24] or that there should be 51 more cases than 
the number of variables, to support X 
2 
testing (ie: n= 63) 
[40], others recommend up to 300 cases [41]. 
CONCLUSION 
 In conclusion, we have used the SSP questionnaire and 
the other measures presented here to describe the psycho-
logical profiles of patients with IBS in comparison with both 
a normal volunteer group and a group of patients with an 
anxiety disorder. We have shown that patients with IBS pre-
senting to a gastroenterology service have anxiety scores that 
are intermediate between that seen in patients with a syn-
dromal anxiety disorder and that of normal volunteers. Fur-
ther, character traits as assessed by the SSP reflect those seen 
in patients with a DSM-IV anxiety disorder with levels of 
somatic trait anxiety, psychic trait anxiety and stress suscep-
tibility being intermediate between untreated patients with 
social anxiety disorder and normal volunteers. Despite this 
intermediate status, IBS patients as a group had normal SSP 
profiles. This may suggest that the depressive and anxious 
tendency of IBS subjects are not related to personality fac-
tors, although such a finding is speculative. IBS subtypes 
differed only with respect to the Lack of Assertiveness vari-
able, which is a finding of uncertain clinical relevance that 
would benefit from replication in future studies. 
 It is also clear that whilst pharmacological treatment of 
patients with anxiety disorders is associated with improved 
anxiety ratings, the residual level of psychological impair-
ment as defined by these scales still differed significantly 
from normal volunteers. It would be interesting to see 
whether successful treatment of patients with IBS normalise 
these scores and whether stress susceptibility is characterised 
by altered HPA and autonomic axes responses to appropriate 
challenge tests. Studies to investigate this are currently un-
derway and we look forward to ongoing refinement of this 
understanding in future publications. 
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